Encyclopedia

chorea

Also found in: Dictionary, Medical, Acronyms, Wikipedia.
(redirected from Huntington's disease)

chorea

a disorder of the central nervous system characterized by uncontrollable irregular brief jerky movements
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005

chorea

[kə′rē·ə]
(medicine)
A nervous disorder seen as part of a syndrome following an organic dysfunction or an infection and characterized by irregular, involuntary movements of the body, especially of the face and extremities.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Chorea

 

a form of hyperkinesia characterized by rapid movements such as twitching of the extremities, winking, and smacking of the lips. It is associated with organic injury to certain subcortical sections of the brain. The most common form is chorea minor, or Sydenham’s chorea, usually found in children and adolescents as an indication of rheumatism. In addition to hyperkinesia, other characteristics of chorea are low muscle tone and such asthenic symptoms as sleeplessness, lacrimation, and irritability. Sydenham’s chorea usually takes a favorable course, but recurrences are possible. The condition known as chorea major, marked by hysterical choreiform twitchings that were observed as a mass phenomenon in the Middle Ages, is now of historical interest only.

Huntington’s chorea (described in 1872 by the American psychiatrist G. Huntington) is a hereditary degenerative disease transmitted as an autosomal dominant trait. It usually occurs between the ages of 35 and 40 and is characterized by chronic progressive deterioration. Muscle tone is low in some cases, and high (with muscular rigidity) in others. The principal characteristics of Huntington’s chorea are such forms of mental deterioration as apathy, loss of memory, intellectual decline, transient delusions, hallucinations, and the gradual development of severe dementia. Other findings in Huntington’s chorea include subcortical lesions and atrophy of the brain cortex.

Sydenham’s chorea is treated with antirheumatic drugs (including salicylates), sedatives, and antiallergens (such as diphenhydramine and chloropyramine). Chlorpromazine and reserpine are prescribed for Huntington’s chorea; drugs used in the case of muscular rigidity include cholinolytic agents (such as trihexyphenidyl hydrochloride), L-dopa, and amantadine hydrochloride.

REFERENCES

Anosov, N. N. “Khoreia Khantingtona.” In Mnogotomnoe rukovodstvopo nevrologii, vol. 7. Leningrad, 1960.
Tsuker, M. B. Infektsionnye zabolevaniia nervnoi sistemy u detei. Moscow, 1963.
Hittyk, L. S. Mala khoreia. Kiev, 1965.

V. A. KARLOV

The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
Mentioned in
References in periodicals archive
Carter et al.; "Reversal of Cellular Phenotypes in Neural Cells Derived from Huntington's Disease Monkey-Induced Pluripotent Stem Cells"; Stem Cell Reports, 2014; DOI: 10.1016/j.stemcr.2014.07.011
* Coverage of the Huntington's Disease pipeline on the basis of route of administration and molecule type.
But in the striatum, the region of the brain that is devastated by Huntington's disease, this capability is "switched off" in adulthood.
Editor's Note: Huntington's disease is a neurodegenerative disorder caused by a genetic error that produces abnormal proteins in the brain's cells.
Huntington's disease gradually takes away the ability to control movements, think normally, and cam for oneself.
Behavioral and psychiatric symptoms associated with Huntington's disease. Adv Neurol.
CHDI and its collaborators have developed a unique series of 20 ES cell lines from genetically modified mouse models that mimic aspects of Huntington's disease. These cell lines and mouse models represent an important tool for medical researchers to use in a wide variety of research programmes in Huntington's disease, a genetic neurological disorder affecting 7 in 100,000 people.
In December 2007, all 12 members of the Food and Drug 'Administration's Peripheral and Central Nervous System Drugs Advisory Committee agreed that available data from a randomized, placebo-controlled study of 84 ambulatory patients with Huntington's disease supported the drug's approval.
Janet Greeson, Chief Executive Officer of Samaritan, commented: "We believe our CNS drugs hold a lot of promise to cognitively improve Alzheimer's patients and protect their brain from further damage; so we are extremely hopeful our drugs will demonstrate and hold the same promise for Huntington's disease."
The high frequency of juvenile Huntington's disease in South Africa.
The FDA issued an "approvable" letter for tetrabenazine for the treatment of chorea associated with Huntington's disease, according to a statement issued by Prestwick.
In addition to its stroke and Huntington's disease programmes, ReNeuron is developing stem cell therapies for Parkinson's disease, Type 1 diabetes and diseases of the retina.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.